To view this email as a web page, click here.

A Treatment Option for Advanced NSCLC and two types of Advanced Skin Cancers

June 22, 2021 • 8:30pm ET (5:30pm PT)

Topics of discussion at this virtual event include:

Clinical trial data for first-line monotherapy in patients with advanced NSCLC with PD-L1 ≥50% based on one of the largest studies in this setting Efficacy and safety finding from clinical trials in advanced CSCC and locally advanced BCC Detailed patient cases from clinical trials

Expert insights provided by:

Chaitali Nangia, MD Director of Head and Neck Oncology for the Verity Health System Chan Soon-Shiong Institute for Medicine Irvine, CA

In accordance with the PhRMA Code on Interactions with Healthcare Professional, this Program is limited to U.S. Healthcare Professionals and persons with bona fide professional interest in the information presented. No CME credits offered for attendance of this program.

Sponsored by

ONC.21.01.0020    6/21

This email was sent by: %%Member_Busname%% %%Member_Addr%%, %%Member_City%%, %%Member_State%%, %%Member_PostalCode%% %%Member_Country%% Privacy Policy Update Profile      Manage Subscriptions      Unsubscribe